| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9852 |
| Human Intestinal Absorption | HIA+ | 0.9926 |
| Caco-2 Permeability | Caco2+ | 0.7776 |
| P-glycoprotein Substrate | Substrate | 0.8298 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8827 |
| Inhibitor | 0.5576 |
| Renal Organic Cation Transporter | Inhibitor | 0.6372 |
| Distribution |
| Subcellular localization | Plasma membrane | 0.4586 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7818 |
| CYP450 2D6 Substrate | Substrate | 0.7478 |
| CYP450 3A4 Substrate | Substrate | 0.6501 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8933 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8976 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6821 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9541 |
| Inhibitor | 0.7619 |
| AMES Toxicity | Non AMES toxic | 0.8320 |
| Carcinogens | Non-carcinogens | 0.8937 |
| Fish Toxicity | High FHMT | 0.5399 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7875 |
| Honey Bee Toxicity | Low HBT | 0.7414 |
| Biodegradation | Not ready biodegradable | 0.9797 |
| Acute Oral Toxicity | III | 0.7407 |
| Carcinogenicity (Three-class) | Non-required | 0.7026 |